France Mentré

25.0k total citations · 2 hit papers
291 papers, 9.3k citations indexed

About

France Mentré is a scholar working on Statistics and Probability, Infectious Diseases and Epidemiology. According to data from OpenAlex, France Mentré has authored 291 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Statistics and Probability, 72 papers in Infectious Diseases and 63 papers in Epidemiology. Recurrent topics in France Mentré's work include Statistical Methods in Clinical Trials (84 papers), Optimal Experimental Design Methods (41 papers) and Statistical Methods and Bayesian Inference (38 papers). France Mentré is often cited by papers focused on Statistical Methods in Clinical Trials (84 papers), Optimal Experimental Design Methods (41 papers) and Statistical Methods and Bayesian Inference (38 papers). France Mentré collaborates with scholars based in France, Switzerland and United States. France Mentré's co-authors include Emmanuelle Comets, Sylvie Retout, Karl Brendel, Marc Lavielle, Jérémie Guedj, Alain Mallet, Cédric Laouenan, Céline M. Laffont, Yazdan Yazdanpanah and Nathan Peiffer‐Smadja and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

France Mentré

282 papers receiving 9.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin

2011 334 citations E. Maubec, Peter Petrow et al. Journal of Clinical Oncology profile →
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

2016 292 citations Andrew C. Hooker, Mats O. Karlsson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
France Mentré France	50	2.3k	1.7k	1.7k	1.1k	1.1k	291	9.3k
Mats O. Karlsson Sweden	58	2.3k 1.0×	1.9k 1.1×	2.0k 1.2×	2.6k 2.3×	2.7k 2.4×	401	15.5k
Stephen B. Duffull New Zealand	47	539 0.2×	688 0.4×	865 0.5×	921 0.8×	1.5k 1.3×	278	8.3k
Lewis B. Sheiner United States	60	1.8k 0.8×	3.3k 1.9×	1.2k 0.7×	2.1k 1.8×	2.7k 2.4×	182	16.4k
Nicholas H. G. Holford New Zealand	59	1.1k 0.5×	999 0.6×	1.1k 0.6×	1.5k 1.3×	3.0k 2.6×	210	12.9k
Stuart L. Beal United States	30	552 0.2×	1.6k 0.9×	633 0.4×	703 0.6×	1.4k 1.2×	52	6.6k
E. Niclas Jonsson Sweden	37	527 0.2×	864 0.5×	600 0.4×	754 0.7×	974 0.9×	90	6.1k
Dean Follmann United States	42	1.1k 0.5×	1.3k 0.8×	1.8k 1.0×	1.1k 0.9×	354 0.3×	170	10.5k
Leon Aarons United Kingdom	37	332 0.1×	932 0.5×	334 0.2×	973 0.9×	967 0.9×	255	5.6k
Michel Tod France	35	492 0.2×	319 0.2×	564 0.3×	686 0.6×	737 0.7×	218	4.0k
Miriam Sturkenboom Netherlands	68	869 0.4×	516 0.3×	2.1k 1.2×	1.4k 1.2×	3.0k 2.7×	461	18.0k

Countries citing papers authored by France Mentré

Since Specialization

Citations

This map shows the geographic impact of France Mentré's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by France Mentré with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites France Mentré more than expected).

Fields of papers citing papers by France Mentré

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by France Mentré. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by France Mentré. The network helps show where France Mentré may publish in the future.

Co-authorship network of co-authors of France Mentré

This figure shows the co-authorship network connecting the top 25 collaborators of France Mentré. A scholar is included among the top collaborators of France Mentré based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with France Mentré. France Mentré is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hooker, Andrew C., Emmanuelle Comets, Andreas Traschütz, et al.. (2024). Longitudinal Analysis of Natural History Progression of Rare and Ultra‐Rare Cerebellar Ataxias Using Item Response Theory. Clinical Pharmacology & Therapeutics. 116(6). 1593–1605. 2 indexed citations

Mentré, France, et al.. (2024). Distributive randomization: a pragmatic fractional factorial design to screen or evaluate multiple simultaneous interventions in a clinical trial. BMC Medical Research Methodology. 24(1). 64–64.

Retout, Sylvie, et al.. (2024). Impact of covariate model building methods on their clinical relevance evaluation in population pharmacokinetic analyses: comparison of the full model, stepwise covariate model (SCM) and SCM+ approaches. Journal of Pharmacokinetics and Pharmacodynamics. 51(6). 653–670. 2 indexed citations

Fougerou‐Leurent, Claire, Christelle Delmas, Juliette Saillard, et al.. (2023). Ensuring quality control in a COVID-19 clinical trial during the pandemic: The experience of the Inserm C20–15 DisCoVeRy study. Contemporary Clinical Trials. 131. 107267–107267.

Belhadi, Drifa, et al.. (2022). The number of cases, mortality and treatments of viral hemorrhagic fevers: A systematic review. PLoS neglected tropical diseases. 16(10). e0010889–e0010889. 9 indexed citations

Lingas, Guillaume, Nadège Néant, Alexandre Gaymard, et al.. (2022). Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial. Journal of Antimicrobial Chemotherapy. 77(5). 1404–1412. 23 indexed citations

Couffignal, Camille, Julien Amour, Bernard Cholley, et al.. (2019). Timing of β-Blocker Reintroduction and the Occurrence of Postoperative Atrial Fibrillation after Cardiac Surgery. Anesthesiology. 132(2). 267–279. 10 indexed citations

Tardivon, Coralie, René Bruno, Benjamin Wu, et al.. (2019). Association Between Tumor Size Kinetics and Survival in Patients With Urothelial Carcinoma Treated With Atezolizumab: Implication for Patient Follow‐Up. Clinical Pharmacology & Therapeutics. 106(4). 810–820. 36 indexed citations

Burdet, Charles, Thu Thuy Nguyen, Perrine Hugon, et al.. (2018). Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection. Antimicrobial Agents and Chemotherapy. 62(10). 21 indexed citations

10.

Beydon, Nicole, Thu Thuy Nguyen, Francis Amsallem, et al.. (2018). Interrupter resistance to measure dose‐response to salbutamol in wheezy preschool children. Pediatric Pulmonology. 53(9). 1252–1259. 4 indexed citations

11.

Laouenan, Cédric, Patrick Marcellin, Martine Lapalus, et al.. (2014). Using Pharmacokinetic and Viral Kinetic Modeling To Estimate the Antiviral Effectiveness of Telaprevir, Boceprevir, and Pegylated Interferon during Triple Therapy in Treatment-Experienced Hepatitis C Virus-Infected Cirrhotic Patients. Antimicrobial Agents and Chemotherapy. 58(9). 5332–5341. 7 indexed citations

12.

Guglielminotti, Jean, et al.. (2013). Assessment of Pain During Labor with Pupillometry. Anesthesia & Analgesia. 116(5). 1057–1062. 33 indexed citations

13.

Carrat, Fabrice, Xavier Duval, Florence Tubach, et al.. (2012). Effect of Oseltamivir, Zanamivir or Oseltamivir– Zanamivir Combination Treatments on Transmission of Influenza in Households. Antiviral Therapy. 17(6). 1085–1090. 25 indexed citations

14.

Maubec, E., Peter Petrow, Isabelle Scheer-Senyarich, et al.. (2011). Phase II Study of Cetuximab As First-Line Single-Drug Therapy in Patients With Unresectable Squamous Cell Carcinoma of the Skin. Journal of Clinical Oncology. 29(25). 3419–3426. 334 indexed citations breakdown →

15.

Quesnel, Christophe, Julien Gelly, Marc Garnier, et al.. (2011). Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury*. Critical Care Medicine. 40(1). 21–28. 34 indexed citations

16.

Bertrand, Julie, Emmanuelle Comets, Marylore Chenel, & France Mentré. (2011). Some Alternatives to Asymptotic Tests for the Analysis of Pharmacogenetic Data Using Nonlinear Mixed Effects Models. Biometrics. 68(1). 146–155. 12 indexed citations

17.

Blanchon, Thierry, France Mentré, A. Mosnier, et al.. (2011). Factors associated with clinical and virological response in patients treated with oseltamivir or zanamivir for influenza A during the 2008–2009 winter. Clinical Microbiology and Infection. 19(2). 196–203. 11 indexed citations

18.

Lavielle, Marc, et al.. (2010). Maximum Likelihood Estimation of Long-Term HIV Dynamic Models and Antiviral Response. Biometrics. 67(1). 250–259. 39 indexed citations

19.

Duval, Xavier, Sylvie van der Werf, Thierry Blanchon, et al.. (2010). Correction: Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial. PLoS Medicine. 7(12). 14 indexed citations

20.

Bindi, Pascal, B. Mougenot, France Mentré, et al.. (1993). Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. QJM. 86(1). 55–68. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact